Cargando…
Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients
Background: Derangement of liver blood tests (LBT) is frequent in patients with Coronavirus disease 2019 (COVID-19). We aimed to evaluate (a) the prevalence of deranged LBT as well as their association with (b) clinical severity at admission and (c) 30-day outcomes among the hospitalized patients wi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470265/ https://www.ncbi.nlm.nih.gov/pubmed/34575333 http://dx.doi.org/10.3390/jcm10184222 |
_version_ | 1784574154532454400 |
---|---|
author | Paštrovic, Frane Lucijanic, Marko Atic, Armin Stojic, Josip Barisic Jaman, Mislav Tjesic Drinkovic, Ida Zelenika, Marko Milosevic, Marko Medic, Barbara Loncar, Jelena Mijic, Maja Filipec Kanizaj, Tajana Kralj, Dominik Lerotic, Ivan Virovic Jukic, Lucija Ljubicic, Neven Luetic, Kresimir Grgic, Dora Majerovic, Matea Ostojic, Rajko Krznaric, Zeljko Luksic, Ivica Piskac Zivkovic, Nevenka Keres, Tatjana Grabovac, Vlatko Persec, Jasminka Barsic, Bruno Grgurevic, Ivica |
author_facet | Paštrovic, Frane Lucijanic, Marko Atic, Armin Stojic, Josip Barisic Jaman, Mislav Tjesic Drinkovic, Ida Zelenika, Marko Milosevic, Marko Medic, Barbara Loncar, Jelena Mijic, Maja Filipec Kanizaj, Tajana Kralj, Dominik Lerotic, Ivan Virovic Jukic, Lucija Ljubicic, Neven Luetic, Kresimir Grgic, Dora Majerovic, Matea Ostojic, Rajko Krznaric, Zeljko Luksic, Ivica Piskac Zivkovic, Nevenka Keres, Tatjana Grabovac, Vlatko Persec, Jasminka Barsic, Bruno Grgurevic, Ivica |
author_sort | Paštrovic, Frane |
collection | PubMed |
description | Background: Derangement of liver blood tests (LBT) is frequent in patients with Coronavirus disease 2019 (COVID-19). We aimed to evaluate (a) the prevalence of deranged LBT as well as their association with (b) clinical severity at admission and (c) 30-day outcomes among the hospitalized patients with COVID-19. Methods: Consecutive patients with COVID-19 hospitalized in the regional referral center over the 12-month period were included. Clinical severity of COVID-19 at hospital admission and 30-day outcomes (need for intensive care, mechanical ventilation, or death) were analyzed. Results: Derangement of LBT occurred in 2854/3812 (74.9%) of patients, most frequently due to elevation of AST (61.6%), GGT (46.1%) and ALT (33.4%). Elevated AST, ALT, GGT and low albumin were associated with more severe disease at admission. However, in multivariate Cox regression analysis, when adjusted for age, sex, obesity and presence of chronic liver disease, only AST remained associated with the risk of dying (HR 1.5081 and 2.1315, for elevations 1–3 × ULN and >3 × ULN, respectively) independently of comorbidity burden and COVID-19 severity at admission. Patients with more severe liver injury more frequently experienced defined adverse outcomes. Conclusions: Deranged LBTs are common among patients hospitalized with COVID-19 and might be used as predictors of adverse clinical outcomes. |
format | Online Article Text |
id | pubmed-8470265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84702652021-09-27 Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients Paštrovic, Frane Lucijanic, Marko Atic, Armin Stojic, Josip Barisic Jaman, Mislav Tjesic Drinkovic, Ida Zelenika, Marko Milosevic, Marko Medic, Barbara Loncar, Jelena Mijic, Maja Filipec Kanizaj, Tajana Kralj, Dominik Lerotic, Ivan Virovic Jukic, Lucija Ljubicic, Neven Luetic, Kresimir Grgic, Dora Majerovic, Matea Ostojic, Rajko Krznaric, Zeljko Luksic, Ivica Piskac Zivkovic, Nevenka Keres, Tatjana Grabovac, Vlatko Persec, Jasminka Barsic, Bruno Grgurevic, Ivica J Clin Med Article Background: Derangement of liver blood tests (LBT) is frequent in patients with Coronavirus disease 2019 (COVID-19). We aimed to evaluate (a) the prevalence of deranged LBT as well as their association with (b) clinical severity at admission and (c) 30-day outcomes among the hospitalized patients with COVID-19. Methods: Consecutive patients with COVID-19 hospitalized in the regional referral center over the 12-month period were included. Clinical severity of COVID-19 at hospital admission and 30-day outcomes (need for intensive care, mechanical ventilation, or death) were analyzed. Results: Derangement of LBT occurred in 2854/3812 (74.9%) of patients, most frequently due to elevation of AST (61.6%), GGT (46.1%) and ALT (33.4%). Elevated AST, ALT, GGT and low albumin were associated with more severe disease at admission. However, in multivariate Cox regression analysis, when adjusted for age, sex, obesity and presence of chronic liver disease, only AST remained associated with the risk of dying (HR 1.5081 and 2.1315, for elevations 1–3 × ULN and >3 × ULN, respectively) independently of comorbidity burden and COVID-19 severity at admission. Patients with more severe liver injury more frequently experienced defined adverse outcomes. Conclusions: Deranged LBTs are common among patients hospitalized with COVID-19 and might be used as predictors of adverse clinical outcomes. MDPI 2021-09-17 /pmc/articles/PMC8470265/ /pubmed/34575333 http://dx.doi.org/10.3390/jcm10184222 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Paštrovic, Frane Lucijanic, Marko Atic, Armin Stojic, Josip Barisic Jaman, Mislav Tjesic Drinkovic, Ida Zelenika, Marko Milosevic, Marko Medic, Barbara Loncar, Jelena Mijic, Maja Filipec Kanizaj, Tajana Kralj, Dominik Lerotic, Ivan Virovic Jukic, Lucija Ljubicic, Neven Luetic, Kresimir Grgic, Dora Majerovic, Matea Ostojic, Rajko Krznaric, Zeljko Luksic, Ivica Piskac Zivkovic, Nevenka Keres, Tatjana Grabovac, Vlatko Persec, Jasminka Barsic, Bruno Grgurevic, Ivica Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients |
title | Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients |
title_full | Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients |
title_fullStr | Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients |
title_full_unstemmed | Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients |
title_short | Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients |
title_sort | prevalence and prognostic impact of deranged liver blood tests in covid-19: experience from the regional covid-19 center over the cohort of 3812 hospitalized patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470265/ https://www.ncbi.nlm.nih.gov/pubmed/34575333 http://dx.doi.org/10.3390/jcm10184222 |
work_keys_str_mv | AT pastrovicfrane prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT lucijanicmarko prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT aticarmin prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT stojicjosip prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT barisicjamanmislav prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT tjesicdrinkovicida prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT zelenikamarko prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT milosevicmarko prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT medicbarbara prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT loncarjelena prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT mijicmaja prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT filipeckanizajtajana prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT kraljdominik prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT leroticivan prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT virovicjukiclucija prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT ljubicicneven prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT luetickresimir prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT grgicdora prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT majerovicmatea prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT ostojicrajko prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT krznariczeljko prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT luksicivica prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT piskaczivkovicnevenka prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT kerestatjana prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT grabovacvlatko prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT persecjasminka prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT barsicbruno prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients AT grgurevicivica prevalenceandprognosticimpactofderangedliverbloodtestsincovid19experiencefromtheregionalcovid19centeroverthecohortof3812hospitalizedpatients |